Syria-bound Russian military jet crashes with 92 onboard

December 25, 2016

Moscow, Dec 25: A Russian military plane crashed today in the Black Sea as it made its way to Syria with 92 people onboard, including Red Army Choir members heading to celebrate the New Year with troops.plane

Local news agencies, citing the defence ministry, said the Tu-154 plane had crashed shortly after take-off from the southern city of Adler at 5:40 am local time.

Defence ministry spokesman Igor Konashenkov told Russian news agencies that one body had been recovered six kilometres off the coast of the resort city of Sochi, as a frantic search operation continued to hunt for the missing.

"Fragments of the Tu-154 plane of the Russian defence ministry were found 1.5 kilometres from the Black Sea coast of the city of Sochi at a depth of 50 to 70 metres," the ministry said.

The plane had been on a routine flight to Russia's Hmeimim airbase in western Syria, which has been used to launch air strikes in Moscow's military campaign supporting its ally President Bashar al-Assad in the country's devastating civil war.

Among the 84 passengers of the plane were Russian servicemen as well as members of the Alexandrov Ensemble, the army's official musical group internationally known as the Red Army Choir, who were headed to Syria to participate in New Year celebrations at the airbase.

There were also eight crew members onboard, the ministry said.

Nine journalists were among the passengers, with state-run channels Pervy Kanal, NTV and Zvezda saying they each had three staff onboard the flight.

Kremlin spokesman Dmitry Peskov told news agencies that President Vladimir Putin had been informed of the situation and was being kept updated on the search operation.

"It's too early to say anything," agencies quoted Peskov as saying, adding that Putin was in constant contact with Defence Minister Sergei Shoigu.

"The president is waiting for the picture to be clear."

Konashenkov said that Deputy Defence Minister Pavel Pop
ov had flown to Adler along with a team tasked with clarifying the circumstances surrounding the crash.

Russia's Investigative Committee said a criminal probe had been launched to determine whether violations of air transportation safety had led to the crash.

Investigators are currently questioning the technical personnel responsible for preparing the plane for take-off, the committee said.

Tu-154 aircraft have been involved in a number of accidents in the past.
In April 2010 many high-ranking Polish officials, including then president Lech Kaczynski, were killed when a Tu-154 airliner went down in thick fog while approaching the Smolensk airport in western Russia.

Moscow has been conducting a bombing campaign in Syria in support of Assad since September 2015 and has taken steps to boost its presence in the country.

In October, Putin approved a law ratifying Moscow's deal with Damascus to deploy its forces in the country indefinitely, firming up Russia's long-term presence in Syria.

Russian warplanes have flown out of the Hmeimim base to conduct air strikes, and the base is also home to an S-400 air defence system.

Comments

HOFZ
 - 
Sunday, 25 Dec 2016

RUSSIAN PRESEDENT PUT IN NOW REALIZING

Abdul
 - 
Sunday, 25 Dec 2016

Innocent people of Syrian children prayer will burn Russia one by one.

Mohammed
 - 
Sunday, 25 Dec 2016

Trust Allha every one........ will be punish...............

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Beijing, Mar 25: Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Y UDAYA CHANDAR
 - 
Monday, 13 Apr 2020

Dear Sir,

 

I am 77 but a very healthy person with remarkable immunity. I contracted Malaria fever in 1994 because of mosquito biting and I have not been sick anytime there after, not even for ordinary fever in the last 26 years.

 

I am sure you would like to conduct the trials on persons of varying criteria. I am sure you don't want to carry out the trials on perfectly healthy young individuals only. 

 

I am certain that  you want to try the vaccine on a 'common man' from 'general public.' I am ready for the trial and you can take me. I will be delighted. 

 

If you are not handling this matter kindly forward this mail to the correct agency.

 

I look forward to hearing from you.

 

Best regards.

 

If you are not moving forward, you are really moving backward.

Y Udaya Chandar

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.